Methyl 10-chloro-10-oxodecanoate

Catalog No.: 
ACFTRU362
CAS No.: 
14065-32-8
Molecular Formula: 
C11H19ClO3
Molecular Weight: 
234.72
Methyl 10-chloro-10-oxodecanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g99%$94.00In stockInquiry
10g99%$148.00In stockInquiry
25g99%$297.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 10-chloro-10-oxodecanoate
IUPAC Namemethyl 10-chloro-10-oxodecanoate
MDL No.MFCD00192320
Molecular FormulaC11H19ClO3
Molecular Weight234.72
SMILESO=C(OC)CCCCCCCCC(Cl)=O
InChI KeyZUUUAAZQEMFVSN-UHFFFAOYSA-N
Synonym9-Chloroformylnonanoic acid methyl ester;Methyl 10-chloro-10-oxodecanoate,98%;Methyl 10-chloro-10-oxodecanoate 97%;SEBACINIC ACID MONOMETHYL ESTER MONOCHLORIDE;MONOMETHYLSEBACOYLCHLORIDE;METHYL SEBACOYL CHLORIDE;METHYL 10-CHLORO-10-OXODECANOATE;10-Oxo-10-chlorodecanoic acid methyl ester
CAS No.14065-32-8

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H314
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACFTRU362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEVZI386 route compound structure diagram
    ACEVZI386818-88-2In Stock
  2. Then
  3. ACFTRU362 route product structure diagram
    ACFTRU36214065-32-8In Stock
Inquiry

2. ACFTRU362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEVZI386 route compound structure diagram
    ACEVZI386818-88-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFTRU362 route product structure diagram
    ACFTRU36214065-32-8In Stock
Inquiry

3. ACFTRU362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFTRU362 route product structure diagram
    ACFTRU36214065-32-8In Stock
Inquiry

Comments (0)